Yesterday’s town hall

Quote
anonymous said:
Welcome to obesity where we’ve been dealing with this for over 2 years. After 2 years, the company finally admitted that it’s not coming back and are no longer giving a date. It’ll be the same for Ozempic, eventually. But don’t forget, the reason you have no ozempic is because there’s no Wegovy. Y’all have ridden that wave for 2 years.
Click to expand...
True. It is a debacle. Just make it one freakin pen for everyone. Is there really any difference btwn 2.0 and 2.4?. The two separate promotions is the biggest farce. But someone is cashing in big!
What will Lilly do? Two different devices too? And, why do we have all these upper management people doing what? I cant keep track of who is who. And why do these pharmacy execution managers do? Send emails telling us we are out of stock? And What is OCS going to do now-- just educate? Isn't that why we have obesity educators? But wait we have no stock!!! Well maybe DCS can educate too?
And now they are switching to a Rybelsus focus? Is anyone tolerating the 14? And all DCS/people are struggling to hit goals? What is the national average for goal attainment? Yet the wall street journal has us reportedly "generating billions of dollars of revenue" and lower interest rates in Denmark.
Lastly, where in the heck can you actually get Ozempic all my pharmacies are on "back order" or allotment?
 






anonymous said:
True. It is a debacle. Just make it one freakin pen for everyone. Is there really any difference btwn 2.0 and 2.4?. The two separate promotions is the biggest farce. But someone is cashing in big!
What will Lilly do? Two different devices too? And, why do we have all these upper management people doing what? I cant keep track of who is who. And why do these pharmacy execution managers do? Send emails telling us we are out of stock? And What is OCS going to do now-- just educate? Isn't that why we have obesity educators? But wait we have no stock!!! Well maybe DCS can educate too?
And now they are switching to a Rybelsus focus? Is anyone tolerating the 14? And all DCS/people are struggling to hit goals? What is the national average for goal attainment? Yet the wall street journal has us reportedly "generating billions of dollars of revenue" and lower interest rates in Denmark.
Lastly, where in the heck can you actually get Ozempic all my pharmacies are on "back order" or allotment?
Click to expand...



but we hit our diversity goals. Wasn’t that the goal?
 






anonymous said:
but we hit our diversity goals. Wasn’t that the goal?
Click to expand...

The incessant whining about "diversity" here borders on the pathological. One might think that you're being paid to post the same inane thing over & over.

Get a grip, Snowflake. We've got much bigger problems than some flavor-of-the-month program that will soon be sundowned.
 






anonymous said:
The incessant whining about "diversity" here borders on the pathological. One might think that you're being paid to post the same inane thing over & over.

Get a grip, Snowflake. We've got much bigger problems than some flavor-of-the-month program that will soon be sundowned.
Click to expand...
As well as the incessant whining about the “incessant whining about diversity.” Both sides should shut the fuck up.
 
























People seem to think that IC exists to maximize their bonus. That’s not was IC is for. IC exists to maximize sales across the entire company. If that means some people get screwed over while some benefit from being in the right place at the right time, so be it. Sorry to be the one to break this to you. I don’t like it any more than you, but that is just how the real world of this business works. You complain about diversity and wokeness, but can’t accept that business doesn’t care about you or your feelings of fairness.
 






Agreed on your IC statement- I just wish we could go back to being a company which creates and provides cutting-edge medications for patients, and that is it. Leave the ideologies, narratives and obsession with skin color ( this combo has unfortunately turned into the religion of our new faithless society) for our personal time.
 






anonymous said:
Agreed on your IC statement- I just wish we could go back to being a company which creates and provides cutting-edge medications for patients, and that is it. Leave the ideologies, narratives and obsession with skin color ( this combo has unfortunately turned into the religion of our new faithless society) for our personal time.
Click to expand...
(Sigh) OK, snowflake. We get yer point, OK?
 






anonymous said:
True. It is a debacle. Just make it one freakin pen for everyone. Is there really any difference btwn 2.0 and 2.4?. The two separate promotions is the biggest farce. But someone is cashing in big!
What will Lilly do? Two different devices too? And, why do we have all these upper management people doing what? I cant keep track of who is who. And why do these pharmacy execution managers do? Send emails telling us we are out of stock? And What is OCS going to do now-- just educate? Isn't that why we have obesity educators? But wait we have no stock!!! Well maybe DCS can educate too?
And now they are switching to a Rybelsus focus? Is anyone tolerating the 14? And all DCS/people are struggling to hit goals? What is the national average for goal attainment? Yet the wall street journal has us reportedly "generating billions of dollars of revenue" and lower interest rates in Denmark.
Lastly, where in the heck can you actually get Ozempic all my pharmacies are on "back order" or allotment?
Click to expand...

I have been wondering same questions.
 






anonymous said:
Agreed on your IC statement- I just wish we could go back to being a company which creates and provides cutting-edge medications for patients, and that is it. Leave the ideologies, narratives and obsession with skin color ( this combo has unfortunately turned into the religion of our new faithless society) for our personal time.
Click to expand...
YES and thank you. you should state this on this afternoon's call! lol
 


















Top Bottom
Back
Quote